Juan Andres, former global head technical operations (manufacturing and supply) at Novartis, has joined Moderna Therapeutics, a Cambridge, Massachusetts-based biotechnology company focusing on messenger RNA (mRNA) therapeutics, as senior vice president of late-stage technical development and manufacturing (beyond human proof of concept, or hPOC).
Andres will be responsible for the scale-up of Moderna’s manufacturing and quality efforts as it continues to advance its pipeline of mRNA medicines and prepares to bring its clinical manufacturing facility on line in 2018. In addition, he will lead efforts aimed at preparing Moderna for Phase III development and commercialization. Mr. Andres will work closely with Moderna President Stephen Hoge, who will continue to lead early stage technical development (pre-hPOC), to help transition between early and late development activities. Andres will be a member of Moderna’s executive committee and report to the company’s Chief Executive Officer Stéphane Bancel.
Andres’ previous roles at Novartis included group Novartis quality head, global head of technical research and development, and global pharmaceutical operations head. Prior to Novartis, Andres worked at Eli Lilly and Company for 18 years in a variety of manufacturing, production and quality roles in the US, Puerto Rico, United Kingdom and Spain, most recently serving as vice president, pharmaceutical manufacturing.
Source: Moderna Therapeutics